» Articles » PMID: 10702308

TAK1 Mitogen-activated Protein Kinase Kinase Kinase is Activated by Autophosphorylation Within Its Activation Loop

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Mar 4
PMID 10702308
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

TAK1, a member of the mitogen-activated kinase kinase kinase family, is activated in vivo by various cytokines, including interleukin-1 (IL-1), or when ectopically expressed together with the TAK1-binding protein TAB1. However, this molecular mechanism of activation is not yet understood. We show here that endogenous TAK1 is constitutively associated with TAB1 and phosphorylated following IL-1 stimulation. Furthermore, TAK1 is constitutively phosphorylated when ectopically overexpressed with TAB1. In both cases, dephosphorylation of TAK1 renders it inactive, but it can be reactivated by preincubation with ATP. A mutant of TAK1 that lacks kinase activity is not phosphorylated either following IL-1 treatment or when coexpressed with TAB1, indicating that TAK1 phosphorylation is due to autophosphorylation. Furthermore, mutation to alanine of a conserved serine residue (Ser-192) in the activation loop between kinase domains VII and VIII abolishes both phosphorylation and activation of TAK1. These results suggest that IL-1 and ectopic expression of TAB1 both activate TAK1 via autophosphorylation of Ser-192.

Citing Articles

Disruption of TIGAR-TAK1 alleviates immunopathology in a murine model of sepsis.

Wang D, Li Y, Yang H, Shen X, Shi X, Li C Nat Commun. 2024; 15(1):4340.

PMID: 38773142 PMC: 11109194. DOI: 10.1038/s41467-024-48708-0.


A severe case of cardiospondylocarpofacial syndrome with a novel MAP3K7 variant.

Nyuzuki H, Ozawa J, Nagasaki K, Nishio Y, Ogi T, Tohyama J Hum Genome Var. 2024; 11(1):8.

PMID: 38383446 PMC: 10881960. DOI: 10.1038/s41439-024-00265-0.


Targeted regulation of TAK1 counteracts dystrophinopathy in a DMD mouse model.

Roy A, Koike T, Joshi A, Tomaz da Silva M, Mathukumalli K, Wu M JCI Insight. 2023; 8(10).

PMID: 37071470 PMC: 10322678. DOI: 10.1172/jci.insight.164768.


CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells.

Zheng Y, Yu M, Chen Y, Xue L, Zhu W, Fu G J Immunol. 2023; 210(9):1222-1235.

PMID: 36961449 PMC: 10156913. DOI: 10.4049/jimmunol.2200639.


HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer.

Xu G, Niu L, Wang Y, Yang G, Zhu X, Yao Y Cell Death Dis. 2022; 13(10):888.

PMID: 36270986 PMC: 9587286. DOI: 10.1038/s41419-022-05335-1.